{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:58:57Z","timestamp":1792627137165,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.gendis.2024.101215","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T11:34:38Z","timestamp":1706960078000},"page":"101215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA"],"prefix":"10.1016","volume":"12","author":[{"given":"Jihua","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6920-7972","authenticated-orcid":false,"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.gendis.2024.101215_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.gendis.2024.101215_bib2","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.3390\/cells10113091","article-title":"Treatment for viral hepatitis as secondary prevention for hepatocellular carcinoma","volume":"10","author":"Alqahtani","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.gendis.2024.101215_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"7916","key":"10.1016\/j.gendis.2024.101215_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41586-022-04857-0","article-title":"Structural insights into the HBV receptor and bile acid transporter NTCP","volume":"606","author":"Park","year":"2022","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gendis.2024.101215_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000206","article-title":"Functional involvement of endothelial lipase in hepatitis B virus infection","volume":"7","author":"Shirasaki","year":"2023","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib7","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-023-40225-w","article-title":"Molecular insights into Spindlin1-HBx interplay and its impact on HBV transcription from cccDNA minichromosome","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2024.101215_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.gendis.2024.101215_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01185-23","article-title":"A CRISPR-based system to investigate HBV cccDNA biology","volume":"97","author":"Seeger","year":"2023","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21505594.2022.2093444","article-title":"Novel therapeutic strategies for chronic hepatitis B","volume":"13","author":"Phillips","year":"2022","journal-title":"Virulence"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12072-020-10099-x","article-title":"Effect of combination treatment based on interferon and nucleos(t)ide analogues on functional cure of chronic hepatitis B: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2020","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.gendis.2024.101215_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17460441.2023.2239701","article-title":"The premise of capsid assembly modulators towards eliminating HBV persistence","volume":"18","author":"Bassit","year":"2023","journal-title":"Expert Opin Drug Discov"},{"issue":"11","key":"10.1016\/j.gendis.2024.101215_bib13","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3390\/cells9112430","article-title":"New insights on molecular mechanism of hepatitis B virus covalently closed circular DNA formation","volume":"9","author":"Marchetti","year":"2020","journal-title":"Cells"},{"issue":"40","key":"10.1016\/j.gendis.2024.101215_bib14","doi-asserted-by":"crossref","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","article-title":"Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses","volume":"111","author":"K\u00f6niger","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007124","article-title":"Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus","volume":"14","author":"Kitamura","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41467-021-21850-9","article-title":"Hepatitis B virus cccDNA is formed through distinct repair processes of each strand","volume":"12","author":"Wei","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.gendis.2024.101215_bib17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/v13081463","article-title":"Mechanism of hepatitis B virus cccDNA formation","volume":"13","author":"Wei","year":"2021","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.gendis.2024.101215_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006784","article-title":"The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation","volume":"13","author":"Long","year":"2017","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.gendis.2024.101215_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02230-18","article-title":"Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA","volume":"93","author":"Sheraz","year":"2019","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","article-title":"Covalently closed circular DNA: the ultimate therapeutic target for curing HBV infections","volume":"75","author":"Martinez","year":"2021","journal-title":"J Hepatol"},{"issue":"16","key":"10.1016\/j.gendis.2024.101215_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103135","article-title":"LINC01431 promotes histone H4R3 methylation to impede HBV covalently closed circular DNA transcription by stabilizing PRMT1","volume":"9","author":"Sun","year":"2022","journal-title":"Adv Sci"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01703079","article-title":"Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell","volume":"8","author":"Bock","year":"1994","journal-title":"Virus Genes"},{"issue":"47","key":"10.1016\/j.gendis.2024.101215_bib23","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","author":"Bock","year":"2001","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib25","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","article-title":"Epigenetic modulation in chronic hepatitis B virus infection","volume":"42","author":"Dandri","year":"2020","journal-title":"Semin Immunopathol"},{"issue":"42","key":"10.1016\/j.gendis.2024.101215_bib28","doi-asserted-by":"crossref","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.gendis.2024.101215_bib29","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.3390\/ijms20174276","article-title":"Mapping the interactions of HBV cccDNA with host factors","volume":"20","author":"Mohd-Ismail","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2024.101215_bib30","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.2147\/IDR.S240472","article-title":"cccDNA maintenance in chronic hepatitis B - Targeting the matrix of viral replication","volume":"13","author":"Dandri","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib31","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.32245","article-title":"HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage","volume":"75","author":"Wang","year":"2022","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib32","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41401-021-00765-7","article-title":"IFN-\u03b1 inhibits HBV transcription and replication by promoting HDAC3-mediated de-2-hydroxyisobutyrylation of histone H4K8 on HBV cccDNA minichromosome in liver","volume":"43","author":"Zhao","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J Hepatol"},{"issue":"21","key":"10.1016\/j.gendis.2024.101215_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01362-22","article-title":"Hepatitis B virus core protein is not required for covalently closed circular DNA transcriptional regulation","volume":"96","author":"Zhong","year":"2022","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib35","doi-asserted-by":"crossref","first-page":"100330","DOI":"10.1016\/j.jhepr.2021.100330","article-title":"Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production","volume":"3","author":"Lucifora","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.31240","article-title":"Rapid turnover of hepatitis B virus covalently closed circular DNA indicated by monitoring emergence and reversion of signature-mutation in treated chronic hepatitis B patients","volume":"73","author":"Huang","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib37","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","article-title":"Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels","volume":"69","author":"Ko","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","article-title":"Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo","volume":"67","author":"Allweiss","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2016.08.022","article-title":"Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B","volume":"66","author":"Lai","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gendis.2024.101215_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2016.05.014","article-title":"Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients","volume":"65","author":"Boyd","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.21299","article-title":"Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients","volume":"44","author":"Laras","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.gendis.2024.101215_bib43","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1073\/pnas.0308478100","article-title":"Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2024.101215_bib44","article-title":"Hepatitis B virus DNA methylation and its potential role in chronic hepatitis B","volume":"25","author":"Low","year":"2022","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib45","first-page":"2285","article-title":"MicroRNA-20 induces methylation of hepatitis B virus covalently closed circular DNA in human hepatoma cells","volume":"20","author":"Moon","year":"2019","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib46","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1186\/s12879-019-4436-y","article-title":"Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA","volume":"19","author":"Bloom","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gendis.2024.101215_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-6700-1_7","article-title":"Detection of HBV cccDNA methylation from clinical samples by bisulfite sequencing and methylation-specific PCR","volume":"1540","author":"Zhang","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"23","key":"10.1016\/j.gendis.2024.101215_bib48","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.3748\/wjg.v27.i23.3182","article-title":"Silencing hepatitis B virus covalently closed circular DNA: the potential of an epigenetic therapy approach","volume":"27","author":"Singh","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","article-title":"Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications","volume":"73","author":"Carrillo-Reixach","year":"2020","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.gendis.2024.101215_bib50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/microorganisms7110533","article-title":"Replenishment of hepatitis B virus cccDNA pool is restricted by baseline expression of host restriction factors in vitro","volume":"7","author":"Brezgin","year":"2019","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101215_bib52","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.29912","article-title":"SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases","volume":"68","author":"Ren","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib53","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cell.2017.06.042","article-title":"Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity","volume":"170","author":"Chen","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Rivi\u00e8re","year":"2015","journal-title":"J Hepatol"},{"issue":"16","key":"10.1016\/j.gendis.2024.101215_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00926-20","article-title":"An alternatively spliced sirtuin 2 isoform 5 inhibits hepatitis B virus replication from cccDNA by repressing epigenetic modifications made by histone lysine methyltransferases","volume":"94","author":"Piracha","year":"2020","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101215_bib56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12032-008-9144-1","article-title":"Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells","volume":"26","author":"Yang","year":"2009","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/dna.2014.2714","article-title":"NIRF, a novel ubiquitin ligase, inhibits hepatitis B virus replication through effect on HBV core protein and H3 histones","volume":"34","author":"Qian","year":"2015","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.gendis.2024.101215_bib58","doi-asserted-by":"crossref","first-page":"118848","DOI":"10.1016\/j.lfs.2020.118848","article-title":"S6K1 inhibits HBV replication through inhibiting AMPK-ULK1 pathway and disrupting acetylation modification of H3K27","volume":"265","author":"Wang","year":"2021","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2018.08.032","article-title":"Histone modifications: insights into their influence on gene expression","volume":"175","author":"Stillman","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13148-020-00928-z","article-title":"IFN-\u03b1 confers epigenetic regulation of HBV cccDNA minichromosome by modulating GCN5-mediated succinylation of histone H3K79 to clear HBV cccDNA","volume":"12","author":"Yuan","year":"2020","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.gendis.2024.101215_bib61","doi-asserted-by":"crossref","first-page":"795388","DOI":"10.3389\/fmicb.2021.795388","article-title":"KAT2A promotes hepatitis B virus transcription and replication through epigenetic regulation of cccDNA minichromosome","volume":"12","author":"Qin","year":"2021","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.gendis.2024.101215_bib62","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1042\/CS20210392","article-title":"SIRT7 restricts HBV transcription and replication through catalyzing desuccinylation of histone H3 associated with cccDNA minichromosome","volume":"135","author":"Yu","year":"2021","journal-title":"Clin Sci"},{"key":"10.1016\/j.gendis.2024.101215_bib63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fcimb.2017.00205","article-title":"Roles of lncRNAs in viral infections","volume":"7","author":"Liu","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"6366","key":"10.1016\/j.gendis.2024.101215_bib64","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.aao0409","article-title":"An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism","volume":"358","author":"Wang","year":"2017","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.gendis.2024.101215_bib65","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1136\/gutjnl-2019-319637","article-title":"Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription","volume":"69","author":"Salerno","year":"2020","journal-title":"Gut"},{"issue":"18","key":"10.1016\/j.gendis.2024.101215_bib66","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.7150\/thno.34273","article-title":"LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"issue":"24","key":"10.1016\/j.gendis.2024.101215_bib67","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.7150\/thno.37173","article-title":"HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome","volume":"9","author":"Yang","year":"2019","journal-title":"Theranostics"},{"issue":"22","key":"10.1016\/j.gendis.2024.101215_bib68","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1042\/CS20200970","article-title":"LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor","volume":"134","author":"Ren","year":"2020","journal-title":"Clin Sci"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib69","doi-asserted-by":"crossref","first-page":"100354","DOI":"10.1016\/j.jhepr.2021.100354","article-title":"Control of APOBEC3B induction and cccDNA decay by NF-\u03baB and miR-138-5p","volume":"3","author":"Faure-Dupuy","year":"2021","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.gendis.2024.101215_bib70","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/apt.15197","article-title":"The antiviral effects of human microRNA miR-302c-3p against hepatitis B virus infection","volume":"49","author":"Hamada-Tsutsumi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gendis.2024.101215_bib71","doi-asserted-by":"crossref","first-page":"118089","DOI":"10.1016\/j.lfs.2020.118089","article-title":"The cooperative complex of Argonaute-2 and microRNA-146a regulates hepatitis B virus replication through flap endonuclease 1","volume":"257","author":"Ji","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.gendis.2024.101215_bib72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.lfs.2018.12.057","article-title":"miRNA-548ah promotes the replication and expression of hepatitis B virus by targeting histone deacetylase 4","volume":"219","author":"Xing","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.gendis.2024.101215_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/srep25901","article-title":"The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state","volume":"6","author":"Alarcon","year":"2016","journal-title":"Sci Rep"},{"issue":"7594","key":"10.1016\/j.gendis.2024.101215_bib74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsi\u00e8re","year":"2016","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.gendis.2024.101215_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00769-18","article-title":"Smc5\/6 antagonism by HBx is an evolutionarily conserved function of hepatitis B virus infection in mammals","volume":"92","author":"Abdul","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.gendis.2024.101215_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105519","article-title":"Identification of critical residues in the regulatory protein HBx for Smc5\/6 interaction and hepatitis B virus production","volume":"211","author":"He","year":"2023","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2021.08.010","article-title":"HBx-induced degradation of Smc5\/6 complex impairs homologous recombination-mediated repair of damaged DNA","volume":"76","author":"Sekiba","year":"2022","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.gendis.2024.101215_bib78","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.gendis.2024.101215_bib79","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.bbrc.2014.07.019","article-title":"HBx affects CUL4\u2013DDB1 function in both positive and negative manners","volume":"450","author":"Guo","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.gendis.2024.101215_bib80","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/cells9040834","article-title":"Hepatitis B virus HBx protein mediates the degradation of host restriction factors through the cullin 4 DDB1 E3 ubiquitin ligase complex","volume":"9","author":"Minor","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib81","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1080\/22221751.2020.1840311","article-title":"Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11","volume":"9","author":"Shen","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"13","key":"10.1016\/j.gendis.2024.101215_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109288","article-title":"Transcriptionally inactive hepatitis B virus episome DNA preferentially resides in the vicinity of chromosome 19 in 3D host genome upon infection","volume":"35","author":"Tang","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2024.101215_bib83","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.antiviral.2019.04.009","article-title":"The retinoic acid receptor (RAR) \u03b1-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA","volume":"168","author":"Nkongolo","year":"2019","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib84","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1096\/fj.201801181R","article-title":"Farnesoid X receptor-\u03b1 is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo","volume":"33","author":"Mouzannar","year":"2019","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib85","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/hep.31217","article-title":"Activation of the liver X receptor pathway inhibits HBV replication in primary human hepatocytes","volume":"72","author":"Zeng","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","article-title":"Inhibition of HBV transcription from cccDNA with nitazoxanide by targeting the HBx-DDB1 interaction","volume":"7","author":"Sekiba","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib87","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/hep4.1339","article-title":"A pilot clinical trial of nitazoxanide in the treatment of chronic hepatitis B","volume":"3","author":"Rossignol","year":"2019","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib88","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/hep.30491","article-title":"Pevonedistat, a neuronal precursor cell-expressed developmentally down-regulated protein 8-activating enzyme inhibitor, is a potent inhibitor of hepatitis B virus","volume":"69","author":"Sekiba","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib89","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13543784.2020.1763302","article-title":"Bile acid\u00a0modulators for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Fiorucci","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib90","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","article-title":"Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx","volume":"74","author":"Cheng","year":"2021","journal-title":"J Hepatol"},{"issue":"18","key":"10.1016\/j.gendis.2024.101215_bib91","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.3390\/ijms22189858","article-title":"Mechanisms of DNA methylation in virus-host interaction in hepatitis B infection: pathogenesis and oncogenetic properties","volume":"22","author":"Zhang","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib92","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000321450","article-title":"Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection","volume":"54","author":"Kim","year":"2011","journal-title":"Intervirology"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrg.2017.80","article-title":"The DNA methyltransferase family: a versatile toolkit for epigenetic regulation","volume":"19","author":"Lyko","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib94","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10238-015-0372-3","article-title":"Hepatitis viruses exploitation of host DNA methyltransferases functions","volume":"16","author":"Pazienza","year":"2016","journal-title":"Clin Exp Med"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2022","article-title":"DNA methyltransferases in virus-associated cancers","volume":"29","author":"Charostad","year":"2019","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02148-20","article-title":"Relative DNA methylation and demethylation efficiencies during postnatal liver development regulate hepatitis B virus biosynthesis","volume":"95","author":"Oropeza","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.gendis.2024.101215_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120946","article-title":"Current trends in development of HDAC-based chemotherapeutics","volume":"308","author":"Cheshmazar","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.gendis.2024.101215_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175216","article-title":"The emerging roles of HDACs and their therapeutic implications in cancer","volume":"931","author":"Hai","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/acs.jmedchem.2c01324","article-title":"Structural and functional landscape of FAD-dependent histone lysine demethylases for new drug discovery","volume":"66","author":"Song","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.gendis.2024.101215_bib100","article-title":"Role of epigenetic modification in interferon treatment of hepatitis B virus infection","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"issue":"21","key":"10.1016\/j.gendis.2024.101215_bib101","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1111\/febs.14094","article-title":"Virus-host interplay in hepatitis B virus infection and epigenetic\u00a0treatment strategies","volume":"284","author":"Hensel","year":"2017","journal-title":"FEBS J"},{"issue":"12","key":"10.1016\/j.gendis.2024.101215_bib102","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.7150\/ijms.26125","article-title":"AGK2, A SIRT2 inhibitor, inhibits hepatitis B virus replication in vitro and in vivo","volume":"15","author":"Yu","year":"2018","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101215_bib103","doi-asserted-by":"crossref","first-page":"S690","DOI":"10.1016\/S0168-8278(17)31855-X","article-title":"Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model","volume":"66","author":"Gilmore","year":"2017","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.gendis.2024.101215_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01824-16","article-title":"Matrix metalloproteinase 9 facilitates hepatitis B virus replication through binding with type I interferon (IFN) receptor 1 to repress IFN\/JAK\/STAT signaling","volume":"91","author":"Chen","year":"2017","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/gutjnl-2020-323126","article-title":"RNA helicase DDX5 enables\u00a0STAT1\u00a0mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes","volume":"71","author":"Sun","year":"2022","journal-title":"Gut"},{"issue":"17","key":"10.1016\/j.gendis.2024.101215_bib106","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00442-20","article-title":"Interferon alpha induces multiple cellular proteins that coordinately suppress hepadnaviral covalently closed circular DNA transcription","volume":"94","author":"Cheng","year":"2020","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.gendis.2024.101215_bib107","doi-asserted-by":"crossref","first-page":"12453","DOI":"10.1093\/nar\/gkaa1000","article-title":"Epigenome engineering: new technologies for precision medicine","volume":"48","author":"Sgro","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gendis.2024.101215_bib108","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-801185-0.00005-2","article-title":"Genome engineering in human cells","volume":"546","author":"Song","year":"2014","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.gendis.2024.101215_bib109","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.addr.2020.05.010","article-title":"In vitro transcribed mRNA for expression of designer nucleases: advantages as a novel therapeutic for the management of chronic HBV infection","volume":"168","author":"Ely","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.gendis.2024.101215_bib110","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cld.2023.05.006","article-title":"Targeting hepatitis B virus DNA using\u00a0designer\u00a0gene editors","volume":"27","author":"Zhang","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gendis.2024.101215_bib111","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.omtn.2023.04.016","article-title":"Transient and tunable CRISPRa regulation of APOBEC\/AID genes for targeting hepatitis B virus","volume":"32","author":"Kostyushev","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.gendis.2024.101215_bib112","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virusres.2017.01.003","article-title":"Advances with using CRISPR\/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus","volume":"244","author":"Moyo","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.gendis.2024.101215_bib113","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.gendis.2024.101215_bib114","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/apt.17105","article-title":"Review article: novel biomarkers in hepatitis B infection","volume":"56","author":"Lok","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.gendis.2024.101215_bib115","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/v14092052","article-title":"Oligonucleotide-based therapies for chronic HBV infection: a primer on biochemistry, mechanisms and antiviral effects","volume":"14","author":"Vaillant","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib116","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3350\/cmh.2022.0012","article-title":"RNA interference as a novel treatment strategy for chronic hepatitis B infection","volume":"28","author":"Hui","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib117","first-page":"125","article-title":"Hepatitis B gene therapy coming to age","volume":"20","author":"Soriano","year":"2018","journal-title":"AIDS Rev"},{"issue":"21","key":"10.1016\/j.gendis.2024.101215_bib118","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","article-title":"Efficacy and safety of bepirovirsen in chronic hepatitis B infection","volume":"387","author":"Yuen","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gendis.2024.101215_bib119","doi-asserted-by":"crossref","first-page":"100167","DOI":"10.1016\/j.jhepr.2020.100167","article-title":"Epigenetics in hepatocellular carcinoma development and therapy: the tip of the iceberg","volume":"2","author":"Fern\u00e1ndez-Barrena","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gendis.2024.101215_bib120","doi-asserted-by":"crossref","first-page":"104824","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: formation, regulation\u00a0and therapeutic potential","volume":"180","author":"Xia","year":"2020","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.gendis.2024.101215_bib121","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jcmgh.2022.05.007","article-title":"HIRA supports hepatitis B virus minichromosome establishment and transcriptional activity in infected hepatocytes","volume":"14","author":"Locatelli","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib122","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gutjnl-2020-322571","article-title":"Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5\/6 complex and silencing of the viral genome in vivo","volume":"71","author":"Allweiss","year":"2022","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.gendis.2024.101215_bib123","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.celrep.2019.11.041","article-title":"Type-I-IFN-stimulated gene TRIM5\u03b3 inhibits HBV replication by promoting HBx degradation","volume":"29","author":"Tan","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.gendis.2024.101215_bib124","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-\u03b1 inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.gendis.2024.101215_bib125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.gendis.2024.101215_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003131","article-title":"Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach","volume":"9","author":"Schiffer","year":"2013","journal-title":"PLoS Comput Biol"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T06:36:50Z","timestamp":1731393410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304224000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2352304224000126"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101215","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101215"}}